{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:47Z","timestamp":1786118627841,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/pap.0b013e31802ef4f2","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T04:42:50Z","timestamp":1166762570000},"page":"42-45","source":"Crossref","is-referenced-by-count":17,"title":["p38 MAPK as a Potential Therapeutic Target for Inflammatory Osteolysis"],"prefix":"10.1097","volume":"14","author":[{"given":"Shi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene P.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar1857","article-title":"Osteoclasts; culprits in inflammatory osteolysis","volume":"8","author":"Teitelbaum","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-\u03b2","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"suppl 2","key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"ii84","DOI":"10.1136\/ard.61.suppl_2.ii84","article-title":"Bone destruction in arthritis","volume":"61","author":"Gravallese","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J Clin Invest"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"R9-6-20210202","first-page":"10","article-title":"Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?","volume":"65","author":"Dayer","year":"2002","journal-title":"J Rheumatol Suppl"},{"key":"R10-6-20210202","first-page":"16","article-title":"The mode of action of cytokine inhibitors","volume":"65","author":"Arend","year":"2002","journal-title":"J Rheumatol Suppl"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.11487","article-title":"Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction","volume":"50","author":"Zwerina","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J Clin Invest"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jbspin.2004.03.004","article-title":"Signal transduction pathways: new targets for treating rheumatoid arthritis","volume":"71","author":"Morel","year":"2004","journal-title":"Joint Bone Spine"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.20042","article-title":"Small molecular anti-cytokine agents","volume":"26","author":"Wagner","year":"2006","journal-title":"Med Res Rev"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/156802606775270323","article-title":"New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase","volume":"6","author":"Peifer","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1568026054985902","article-title":"The biology of p38 kinase: a central role in inflammation","volume":"5","author":"Schieven","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/endo.143.8.8954","article-title":"p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function","volume":"143","author":"Li","year":"2002","journal-title":"Endocrinol"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/art.21626","article-title":"Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction","volume":"54","author":"Zwerina","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K","article-title":"Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1357-4310(99)01544-0","article-title":"p38 MAPK signalling cascades in inflammatory disease","volume":"5","author":"Herlaar","year":"1999","journal-title":"Mol Med Today"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(99)01717-2","article-title":"The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts","volume":"465","author":"Suzuki","year":"2000","journal-title":"FEBS Lett"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/oxfordjournals.jbchem.a022231","article-title":"Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by glucocorticoids","volume":"124","author":"Miyazawa","year":"1998","journal-title":"J Biochem (Tokyo)"},{"key":"R24-6-20210202","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","article-title":"The p38\/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor","volume":"15","author":"Beyaert","year":"1996","journal-title":"EMBO J"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1093\/emboj\/18.18.4969","article-title":"The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism","volume":"18","author":"Winzen","year":"1999","journal-title":"EMBO J"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1074\/jbc.M110676200","article-title":"Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction","volume":"277","author":"Paccani","year":"2002","journal-title":"J Biol Chem"},{"key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"13680","DOI":"10.1074\/jbc.M211570200","article-title":"Concomitant recruitment of ERK1\/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes","volume":"278","author":"Berenbaum","year":"2003","journal-title":"J Biol Chem"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.173.8.4838","article-title":"Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo","volume":"173","author":"Kitaura","year":"2004","journal-title":"J Immunol"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"key":"R31-6-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.1998.4320","article-title":"Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells","volume":"247","author":"Jimi","year":"1999","journal-title":"Exp Cell Res"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/endo.142.3.8031","article-title":"Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors","volume":"142","author":"Wei","year":"2001","journal-title":"Endocrinol"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1074\/jbc.M104957200","article-title":"Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling","volume":"277","author":"Wei","year":"2002","journal-title":"J Biol Chem"},{"key":"R34-6-20210202","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M001229200","article-title":"Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)","volume":"275","author":"Matsumoto","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00125480-200701000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:19:25Z","timestamp":1786033165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00125480-200701000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e31802ef4f2","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}